Citations
Altmetric:
Soloist
Composer
Publisher
Date
5/1/2023
Additional date(s)
Abstract
Research Question: This study aimed to address the question: did patients with a history of mood disorder experience a significant change in depression symptomology after the onset and during the COVID-19 pandemic?
Background, Significance, and Rationale: The COVID-19 pandemic represented an unprecedented challenge to the psychological, physical, social, and economic well-being of the global population. The impact on mental health and incidence of depression has been of particular interest. This study seeks to longitudinally examine changes in depressive symptomology before and during the COVID-19 pandemic across age ranges in patients with a history of mood disorder.
Materials and Methods: A secondary analysis was conducted from a pre-existing longitudinal Dallas 2k study examining changes in patient-reported measures of depression severity using the PHQ-9 and QIDS-SR16 from December 2019 to December 2020. A paired t-test analysis was used to determine the effect of various stages of the pandemic during 2020 among age groups.
Results: 189 participants completed the Quick Inventory of Depressive Symptomology (QIDS-SR16) and met the inclusion criteria across four quarterly periods from November 2019 to December 2020. 182 participants completed the Patient Health Questionnaire-9 and met the inclusion criteria. Middle-aged adults (aged 26-64) experienced a significant increase in depression during the onset of the pandemic from March-May 2020. There was no significant change in depression from pre-pandemic scores for middle-aged adults for the remainder of 2020. These findings were consistent among the QIDS-SR16 and PHQ-9.
Conclusions: Middle-aged adults appeared to experience the greatest impact of the onset of the COVID-19 pandemic on depression and this effect did not persist during subsequent periods. These findings suggest that adults were able to demonstrate recovery and resilience during the pandemic.
Background, Significance, and Rationale: The COVID-19 pandemic represented an unprecedented challenge to the psychological, physical, social, and economic well-being of the global population. The impact on mental health and incidence of depression has been of particular interest. This study seeks to longitudinally examine changes in depressive symptomology before and during the COVID-19 pandemic across age ranges in patients with a history of mood disorder.
Materials and Methods: A secondary analysis was conducted from a pre-existing longitudinal Dallas 2k study examining changes in patient-reported measures of depression severity using the PHQ-9 and QIDS-SR16 from December 2019 to December 2020. A paired t-test analysis was used to determine the effect of various stages of the pandemic during 2020 among age groups.
Results: 189 participants completed the Quick Inventory of Depressive Symptomology (QIDS-SR16) and met the inclusion criteria across four quarterly periods from November 2019 to December 2020. 182 participants completed the Patient Health Questionnaire-9 and met the inclusion criteria. Middle-aged adults (aged 26-64) experienced a significant increase in depression during the onset of the pandemic from March-May 2020. There was no significant change in depression from pre-pandemic scores for middle-aged adults for the remainder of 2020. These findings were consistent among the QIDS-SR16 and PHQ-9.
Conclusions: Middle-aged adults appeared to experience the greatest impact of the onset of the COVID-19 pandemic on depression and this effect did not persist during subsequent periods. These findings suggest that adults were able to demonstrate recovery and resilience during the pandemic.
Contents
Subject
Subject(s)
Research Projects
Organizational Units
Journal Issue
Genre
Description
Format
Department
Burnett School of Medicine